Apparatus and method for monitoring tissue vitality parameters

• US 7,130,672 B2
• Filed: 09/25/2001
• Issued: 10/31/2006
• Est. Priority Date: 09/25/2000
• Status: Expired due to Fees

• Current Assignee: CritiSense Ltd.
• Original Assignee: CritiSense Ltd.
• Inventors: Pewzner, Eliahu, Mayevsky, Avraham
• Primary Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US10/381,383
• Publication Number:
  US 20040054270A1
• Time in Patent Office: 1,862 Days
• Field of Search: 600309-310, 600322-323, 600/473, 600/476, 600/324, 600/326, 600/504
• US Class Current: 600/324
• CPC Class Codes: A61B 2562/0242 for varying or adjusting the optical path length in the tissue
• CPC Class Codes: A61B 5/0261 using optical means, e.g. infrared light
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/14553 specially adapted for cerebral tissue

Abstract

Apparatus for monitoring a plurality of tissue viability parameters of a tissue layer element, in which two different illumination sources are used via a common illumination element in contact with the tissue. One illumination source is used for monitoring blood flow rate and optionally flavoprotein concentration, and collection fibers are provided to receive the appropriate radiation from the tissue. The other illuminating radiation is used for monitoring any one of and preferably all of NADH, blood volume and blood oxygenation state of the tissue element, and collection fibers are provided to receive the appropriate radiation from the tissue. In one embodiment, the wavelengths of the two illumination sources are similar, and common collection fibers for the two illuminating radiations are used. In another embodiment, the respective collection fibers are distanced from the illumination point at different distances correlated to the ratio of the first and second illuminating wavelengths.

Claims

1. Apparatus for monitoring viability of a tissue element comprising:

a) at least one light source that illuminates the tissue element from at least one illumination location with at least first illuminating radiation at a first wavelength and second illuminating radiation at a second wavelength;

b) first and second radiation receivers located at first and second distances from the at least one illumination location respectively and at least one radiation detector operatively coupled with said first and second radiation receivers which generates first and second signals respectively responsive to illuminating the tissue element with the first and second illuminating radiations; and

C) a processor that processes the signals to determine first and second tissue viability parameters for the tissue element;

wherein the first and second distances are determined responsive substantially only to the first and second wavelengths and tissue characteristics so that sample depths for the first and second illuminating radiations are substantially equal; and

further

wherein the first tissue viability parameter is different than the second tissue viability parameter.

2. Apparatus as claimed in claim 1, wherein a ratio of said first distance to said second distance is substantially correlated to a ratio of said second wavelength to said first wavelength.

3. Apparatus as claimed in claim 1, wherein said first wavelength is substantially different from said second wavelength.

4. Apparatus according to claim 3, wherein the scattering coefficient in the tissue element differs substantially for light of the first and second wavelengths.

5. Apparatus according to claim 3, wherein the absorption coefficient in the tissue element differs substantially for light of the first and second wavelengths.

6. Apparatus as claimed in claim 1, wherein said first wavelength and said second wavelength have substantially similar penetration depth with respect to said tissue element.

7. Apparatus as claimed in claim 6, wherein a ratio of said first distance to said second distance is substantially unity.

8. Apparatus as claimed in claim 6, wherein said first wavelength is substantially the same as said second wavelength.

9. Apparatus as claimed in claim 8, wherein said first radiation receiver and said second radiation receiver are comprised of at least one common third optical fiber capable of being brought into registry with said tissue element.

10. Apparatus as claimed in claim 9, wherein the at least one illumination location comprises a common illumination location for the first and second illumination radiation, provided by at least one excitation optical fiber capable of being brought into registry with said tissue element.

11. Apparatus as claimed in claim 10, wherein said at least one excitation optical fiber and said at least one common third optical fiber are housed in a suitable probe head.

12. Apparatus as claimed in claim 1, wherein said light source of the second illuminating radiation comprises a suitable monochromatic light source.

13. Apparatus as claimed in claim 12, wherein second wavelength is chosen to lie at a suitable isosbestic point.

14. Apparatus as claimed in claim 13, wherein said isosbestic point is within a substantially isosbestic range of the oxyhaemoglobin-deoxyhaemoglobin absorption vs. wavelength curves.

15. Apparatus as claimed in claim 12, wherein said second wavelength is within the range of wavelengths corresponding to a NADH excitation spectrum.

16. Apparatus as claimed in claim 12, wherein said second wavelength is between about 300 nm and about 395 nm.

17. Apparatus as claimed in claim 12, wherein said second wavelength is within about ±

5 nm of any of the following wavelengths;

325 nm, 337 nm, 349 nm, 355 nm, 366 nm, 370 nm, 384 nm or 390 nm.

18. Apparatus as claimed in claim 12, wherein said second illuminating radiation is provided by any suitable UV light source.

19. Apparatus as claimed in claim 1, wherein said second tissue viability parameter is NADH concentration, and said second radiation received by said second radiation receiver is an NADH fluorescence emitted by the tissue element in response to illumination thereof by said second illuminating radiation, said second tissue viability parameter being provided by the intensity of said NADH fluorescence.

20. Apparatus as claimed in claim 19, wherein said at least one detector comprises a second detector for detecting said second radiation received by said second radiation receiver.

21. Apparatus as claimed in claim 1, wherein said second tissue viability parameter is blood volume within said tissue element, and said second radiation received by said second radiation receiver is a reflection from the tissue element in response to illumination thereof by said second illuminating radiation;

the said second tissue viability parameter being provided by the intensity of said reflection.

22. Apparatus as claimed in claim 21, wherein said at least one detector comprises a third detector for detecting said second radiation received by said second radiation receiver.

23. Apparatus as claimed in claim 1, wherein said second tissue viability parameter is blood oxygeneration ratio within said tissue element, and said second radiation received by said second radiation receiver is a fluorescence emitted by the tissue element in response to illumination thereof by said second illuminating radiation, said second tissue viability parameter being provided by the intensity of said fluorescence at least at two fluorescent wavelengths.

24. Apparatus as claimed in claim 23, wherein one of said at least two fluorescent wavelength is chosen to lie at an oxy-deoxy fluorescence emission isosbestic point.

25. Apparatus as claimed in claim 23, wherein one of said at least two fluorescent wavelengths is higher and another one of said at least two fluorescent wavelengths is smaller than a wavelength corresponding to an oxy-deoxy fluorescence emission isosbestic point.

26. Apparatus as claimed in claim 23, wherein said at least one detector comprises a fourth detector for detecting said second radiation received by said second radiation receiver.

27. Apparatus according to claim 1, wherein the first tissue viability parameter is a blood flow rate tissue viability parameter.

28. Apparatus as claimed in claim 27, wherein said light source of the first illuminating radiation comprises a coherent light source.

29. Apparatus as claimed in claim 28 wherein said blood flow rate tissue viability parameter is provided by the Doppler shift of said first radiation received by said first radiation receiver with respect to the said first illuminating radiation.

30. Apparatus as claimed in claim 29, wherein said at least one detector comprises a first detector for detecting said first radiation received by said first radiation receiver.

31. Apparatus as claimed in claim 28, wherein said coherent light source is a laser light source.

32. Apparatus as claimed in claim 31, wherein said laser light source is adapted to provide said first illuminating radiation of said first wavelength in pulses of predetermined duration and intensity.

33. Apparatus as claimed in claim 32, further comprising a suitable controller for controlling the frequency of pulsing of said pulses.

34. Apparatus as claimed in claim 33, wherein said controller is further adapted to provide said pulses in packages of pulses, each package comprising at least one pulse and separated from a preceding or following package by a predetermined time period.

35. Apparatus as claimed in claim 34, wherein said predetermined time period is greater than the time interval between consecutive pulses within a package.

36. Apparatus as claimed in claim 35, wherein said time period is controllably variable.

37. Apparatus as claimed in claim 34, wherein the number of pulses within each package is controllably variable.

38. Apparatus as claimed in claim 34, wherein said controller is operatively connected to said at least one detector.

39. Apparatus as claimed in claim 33, wherein said controller is selectively responsive to previously detected signals corresponding to the detection of said second radiation detected by means of said at least one detector.

40. Apparatus as claimed in claim 27, wherein said first wavelength is between about 300 nm and about 440 nm.

41. Apparatus as claimed in claim 27, wherein said first wavelength is greater than about 440 nm and is within the visible or near infrared wavelength range.

42. Apparatus as claimed in claim 27, wherein said first wavelength is either in the range 410±

30 nm or within about ±

5 nm of any one of the following wavelengths;

355 nm, 430 nm, 440 nm, 455 nm, 460 nm, 490 nm, 532 nm or 805 nm.

43. Apparatus as claimed in claim 27, for further monitoring a flavoprotein concentration tissue vitality parameter, wherein said at least one detector comprises a fifth detector for detecting a portion of said first radiation received by said first radiation receiver, said portion of said received first radiation being a flavoprotein fluorescence emitted by said tissue element in response to illumination thereof by said first illuminating radiation, said flavoprotein tissue viability parameter being provided by the intensity of said flavoprotein fluorescence.

44. Apparatus as claimed in claim 43, wherein said first wavelength is within the range of wavelengths corresponding to a flavoprotein excitation spectrum.

45. Apparatus as claimed in claim 43, wherein said first wavelength is between about 440 nm and 470 nm.

46. Apparatus according to claim 1, wherein the at least one illumination location comprises a common illumination location for the first and second illuminating radiation.

47. Apparatus as claimed in claim 46, wherein said common illumination location is provided by at least one excitation optical fiber capable of being brought into registry with said tissue element.

48. Apparatus as claimed in claim 47, wherein said first radiation receiver comprises at least one suitable first receiving optical fiber capable of being brought into registry with said tissue element.

49. Apparatus as claimed in claim 48, wherein said second radiation receiver comprises at least one suitable second receiving optical fiber capable of being brought into registry with said tissue element.

50. Apparatus as claimed in claim 49, wherein said at least one excitation optical fiber, said at least one first receiving optical fiber and said at least one second receiving optical fiber are housed in a suitable probe head.

51. Apparatus according to claim 1, wherein the first and second radiation receivers comprise a probe, and the at least one light source illuminates the tissue element through the probe.

52. A method for monitoring first and second tissue viability parameters of a tissue element, the method comprising:

a) illuminating the tissue element from at least one illumination location with first and second illuminating radiations at respectively first and second wavelengths;

b) determining first and second distances from the at least one illumination location responsive substantially only to the first and second wavelengths and tissue characteristics so that sample depths for the first and second illuminating radiations for the first and second distances are substantially equal;

c) receiving radiations at the first and second distances responsive respectively to illuminating the tissue element with the first and second illuminating radiation, and generating first and second signals responsive thereto;

d) determining first and second tissue viability parameters responsive to the first and second signals; and

e) outputting an indication of tissue viability based on said determined tissue viability parameters.